Genetic association analysis of lipid-lowering drug target genes in chronic kidney disease
Yi Zhang,
No information about this author
Guangyang Ou,
No information about this author
Peng Lei
No information about this author
et al.
Frontiers in Endocrinology,
Journal Year:
2025,
Volume and Issue:
15
Published: Jan. 14, 2025
The
impact
of
lipid-lowering
medications
on
chronic
kidney
disease
(CKD)
remains
a
subject
debate.
This
Mendelian
randomization
(MR)
study
aims
to
elucidate
the
potential
effects
drug
targets
CKD
development.
We
extracted
11
genetic
variants
encoding
drugs
from
published
genome-wide
association
(GWAS)
summary
statistics,
encompassing
LDLR,
HMGCR,
PCSK9,
NPC1L1,
APOB,
ABCG5/ABCG8,
LPL,
APOC3,
ANGPTL3,
and
PPARA.
A
analysis
was
conducted
targeting
these
drug-related
genes.
risk
designated
as
primary
outcome,
while
estimated
glomerular
filtration
rate
(eGFR)
blood
urea
nitrogen
(BUN)
were
assessed
secondary
outcomes.
Additionally,
mediation
performed
utilizing
731
immune
cell
phenotypes
identify
mediators.
meta-analysis
revealed
significant
between
ANGPTL3
inhibitors
reduced
(OR
[95%
CI]
=
0.85
[0.75-0.96]).
Conversely,
LDLR
agonists
significantly
linked
an
increased
1.11
[1.02-1.22]).
Regarding
outcomes,
did
not
affect
eGFR
BUN
levels.
Mediation
indicated
that
reduction
in
by
mediated
through
modulation
phenotype,
specifically
HLA-DR
CD14+
CD16+
monocytes
(Mediated
proportion:
4.69%;
Mediated
effect:
-0.00899).
Through
drug-targeted
MR
analysis,
we
identified
causal
relationship
CKD.
may
represent
promising
candidate
for
treatment.
Language: Английский
Plasma proteins and coronary atherosclerosis: A Mendelian randomization study
Henan Pan,
No information about this author
Zongkai Wu,
No information about this author
Yaran Gao
No information about this author
et al.
Medicine,
Journal Year:
2025,
Volume and Issue:
104(8), P. e41549 - e41549
Published: Feb. 21, 2025
Coronary
atherosclerosis
(AS)
is
a
complicated
and
severe
chronic
pathological
process
that
contributes
to
the
basis
of
various
cardiovascular
diseases,
which
causes
serious
challenge
global
healthcare
system.
AS
underlying
physiopathological
mechanism.
Despite
recent
advances
in
research
biomarkers
therapeutic
targets
for
AS,
there
remain
significant
limitations
current
targeted
therapies
AS.
This
study
utilizes
Mendelian
randomization
analysis
leverage
genetic
variations
order
identify
plasma
proteins
with
causal
relationships
coronary
Utilizing
publicly
available
genome-wide
association
datasets,
4907
were
assessed
as
exposure
factors,
being
outcome
variable.
The
primary
analytical
method
employed
was
inverse
variance
weighted
approach
ensure
robustness
accuracy
relationships.
In
addition,
verify
reliability
results,
we
several
complementary
methods,
including
median,
randomization-Egger,
mode,
simple
mode
approaches,
thoroughly
assess
heterogeneity
pleiotropy
findings.
To
results
exclude
potential
biases,
leave-one-out
sensitivity
performed.
Twenty
analyzed
identified
(
P
<
.05),
combined
multiple
bioinformatic
analyses;
among
them,
fibronectin
1
key
target.
These
findings
may
provide
new
theoretical
future
drug
development
strategies.
Language: Английский
Causal relationship between benign prostatic hyperplasia and prostate cancer: a bidirectional Mendelian randomization analysis
Yi Zhang,
No information about this author
Guangyang Ou,
No information about this author
Rongkang Li
No information about this author
et al.
Postgraduate Medical Journal,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 15, 2024
Abstract
Objective
Our
aim
is
to
explore
the
relation
between
benign
prostatic
hyperplasia
(BPH)
and
prostate
cancer
(PCa)
from
a
genetic
level
utilizing
Mendelian
randomization
(MR).
Methods
The
IEU
genome-wide
association
studies
database
was
surveyed
for
single
nucleotide
polymorphisms
(SNPs)
associated
with
BPH,
PCa,
PCa
(validation
cohort).
Single
were
subjected
stringent
quality
control
based
on
rigorous
screening
criteria.
BPH
risk
evaluated
using
inverse-variance
weighted
method
(IVW),
MR-Egger,
simple
mode,
median,
mode.
Horizontal
pleiotropy
of
assessed
MR-Egger
intercept
test,
while
heterogeneity
Cochran’s
Q
test.
Reverse
causality
by
evaluating
as
exposure
outcome.
A
validation
used
verify
Results
increased
significantly
genetically
predicted
(IVW:
OR
[95%
CI]
=
1.3849
×
107
[2330,
8.2294
1010],
P
2.0814
10−4).
In
reverse
MR
analysis,
also
1.0011
[1.0003,
1.0019],
0.0031).
findings
consistent
analysis
results
cohort.
Sensitivity
analyses
indicated
presence
but
no
horizontal
pleiotropy.
Conclusion
study
presents
proof
significant
bidirectional
causal
relationship
an
PCa.
Key
message
Three
research
questions
three
bullet
points
What
already
known
this
topic?
Observational
suggest
controversial
allows
investigation
variants
instrumental
variables
(IVs).
does
add?
How
might
affect
research,
practice,
or
policy?
Recognizing
men
diagnosed
may
benefit
more
protocols.
Language: Английский